Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease



Status:Recruiting
Conditions:Anemia
Therapuetic Areas:Hematology
Healthy:No
Age Range:12 - 18
Updated:9/29/2018
Start Date:December 1, 2017
End Date:June 30, 2020
Contact:Sarah R Martin, PhD
Email:srmartin@mednet.ucla.edu
Phone:310-500-8680

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to test the effects of a laboratory-based hypnosis session
compared to an attention control condition on peripheral blood flow, autonomic stress
responses, and acute pain responses in adolescents (ages 12-18) with sickle cell disease, and
examine how perceived disease-related stigma may affect these responses.


Inclusion Criteria:

- A diagnosis of sickle cell disease

- Age 12-18 years old

- Fluent in English (the intervention will be delivered in English)

- Participant is cognitively able to provide informed signed consent or assent

- Participant is cognitively able to follow instructions

Exclusion Criteria:

- Under 12 years of age or over 18 years of age

- Not fluent in English

- Pain medication prescription has changed or if they have been hospitalized for a
vaso-occlusive episode within 30 days of study participation.

- Diagnosis of a condition (e.g., neurological disorder affecting peripheral sensation,
skin abnormality over the stimulus site, obstructive sleep apnea, diabetes, ischemic
heart disease) or cognitive impairment that may affect data integrity or the ability
to complete study procedures.
We found this trial at
1
site
University of California at Los Angeles
Los Angeles, California 90095
310-825-4321
Phone: 310-825-6964
University of California at Los Angeles The University of California, Los Angeles (UCLA) is an...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials